Michael Castor shared three investment ideas with us in late February 2013. We shared those ideas in the Marketwatch article. First idea was Cardinal Health (CAH). It went up more than 60% since that interview. Guess what? This was also Castor’s worst performing pick among the three he shared with us.
The second investment idea that Castor shared with us was NPS Pharma (NPS). It was trading below $8 at the time. Today, the stock is trading at $27. A return of 250%!!
The third investment idea that we shared in that Marketwatch article was Anacar Pharma (ANAC). Anacor was trading at $3.27 on the day we interviewed Michael Castor. Today it is trading at $28.
It returned a whopping 800%!!! Who would have a guessed an ordinary Marketwatch article would reveal three market crushing stock picks. This article shows that it may be possible to identify truly talented hedge fund managers in advance.
This is just the beginning of the story.
In June 2013, we interviewed Michael Castor one more time and published this interview in the first issue of our monthly newsletter. You can download a free copy of this newsletter here.
Michael Castor picked two stocks in that interview. The first stock is Rockwell Medical (RMTI) which was trading at $4.09 at the time we published the newsletter. Nobody had any respect for Castor’s stock picks at that time. Rockwell Medical went down to $3.40 within a month, so investors had plenty of opportunities to buy this stock cheaply. Rockwell Medical took off after July and today it trades at north of $10. Castor sold this stock at around $8 for a 100% return.
The second stock Castor picked in June 2013 was Mazor Robotics (MZOR). This stock was trading at $11.35 when Castor recommended it and it went up as high as $25 in less than a year. Castor also sold this stock at low $20s for a gain of 100%.
After these picks succeeded we had a few subscribers thanking us. One of them sent us a bottle of expensive wine. Unfortunately nobody has a 100% betting average in investing. In September Michael Castor picked Aratana Therapeutics (PETX) when it was trading at $15. The stock quickly climbed all the way up to $28. However, Castor never told us to exit this stock pick (he still owns it) and the stock currently trades at $11. We consider this pick as a 25% loser.
At the beginning of October 2013 Castor picked Galena Biopharma (GALE) at $2.40. This stock climbed as high as $7, however Castor sold it around $3.50 for a 50% gain.
One of the best picks of Michael Castor came in mid December 2013: Furiex (FURX). Furiex was trading at $40 at the time. By early February it jumped above $100 and was later taken over by Forest Labs for $105. A gain of 160%.
This year Castor picked 4 stocks for us. One in January, one in February, and two in August. We won’t reveal the name of the January pick because this stock has a long way to go even though it is up more than 60%.
I will reveal the name of Castor’s February pick shortly.